首页> Virology> Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study.

Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Rene,Geissler

第一单位： Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.

作者： Rene,Geissler ^[1] ; Ilona,Hauber ^[2] ; Nancy,Funk ^[1] ; Annekatrin,Richter ^[3] ; Martina,Behrens ^[1] ; Ivonne,Renner ^[1] ; Jan,Chemnitz ^[2] ; Helga,Hofmann-Sieber ^[2] ; Heidi,Baum ^[1] ; Jan,van Lunzen ^[4] ; Jens,Boch ^[3] ; Joachim,Hauber ^[5] ; Sven-Erik,Behrens ^[6]

作者单位： Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany. ^[1] Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany. ^[2] Institute of Biology, Department of Genetics, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany. ^[3] Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany; University Medical Center Hamburg-Eppendorf, Infectious Diseases Unit, Hamburg, Germany. ^[4] Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany. ^[5] Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany. Electronic address: sven.behrens@biochemtech.uni-halle.de. ^[6]